- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01973556
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) Demonstration Project
October 25, 2013 updated by: Jan Hirsch, University of California, San Diego
Patients managed by a newly formed pharmacist-physician medication therapy management team in a university primary care clinic will have better blood pressure control than patients receiving usual care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92093
- University of California San Diego
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18 years or over
- diagnosis of hypertension with most recent blood pressure >140/90 mmHg or blood pressure >130/80 mmHg if patients also had diabetes mellitus
- treated with at least one anti-hypertensive medication
- continuous active patient (at least one visit) of the clinic for at least the past 6 months (1/1/2010-6/31/2010)
- English speaking
- Able to complete questionnaires in English.
Exclusion Criteria:
-do not meet provisions of the clinical collaborative agreement protocol in the judgment of the patient's physician or the clinical pharmacist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
|
|
Experimental: Pharmacist-Physician Collaborative Medication Management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
systolic blood pressure
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
October 25, 2013
First Submitted That Met QC Criteria
October 25, 2013
First Posted (Estimate)
October 31, 2013
Study Record Updates
Last Update Posted (Estimate)
October 31, 2013
Last Update Submitted That Met QC Criteria
October 25, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20095191
- 100492 (Other Identifier: UCSD Human Subjects Protection Program)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Pharmacist-Physician Collaborative Medication Therapy Management
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
US Department of Veterans AffairsIcahn School of Medicine at Mount Sinai; University of VictoriaCompleted
-
Providence Health & ServicesTerminated
-
Middle Tennessee Research InstituteAmerican Society of Health-System Pharmacists Research and Education FoundationUnknownMyocardial Infarction | Coronary Heart DiseaseUnited States
-
Centre de recherche du Centre hospitalier universitaire...CompletedPotentially Inappropriate Medication Use
-
Tabula Rasa HealthCareCompletedPharmacogenomics | Medication Therapy ManagementUnited States
-
University of Louisiana MonroeOchsner Health SystemCompletedHypertension | Blood PressureUnited States
-
University of Illinois at ChicagoDuke University; Baylor Research Institute; RTI International; Agency for Healthcare...CompletedElderly Patients | Chronic Illness | Adverse Effects | Medication ErrorsUnited States
-
Shaoxing Maternity and Child Health Care HospitalRecruiting